Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723973 | SCV000227918 | uncertain significance | not provided | 2014-06-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723973 | SCV000250384 | uncertain significance | not provided | 2014-06-03 | criteria provided, single submitter | clinical testing | p.Asp1116Glu (GAC>GAA): c.3348 C>A in exon 22 of the FLNA gene (NM_001456.3) The D1116E variant was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Although the D1116E variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties; the D1116 residue is highly conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, no missense mutations in nearby residues have been reported in association with periventricular heterotopia, Ehlers-Danlos variant.Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. This variant was found in TAAD |
Labcorp Genetics |
RCV002517695 | SCV003462434 | likely benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2022-03-17 | criteria provided, single submitter | clinical testing |